This inventor holds 1 USPTO granted patent. Top assignee: Takeda Chemical Industries, Inc.. Active years: 1977.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1977
Title: Shigetaka Matsuzawa: Innovator in Serological Reagents
Introduction
Shigetaka Matsuzawa is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of serological reagents, particularly through his innovative patent. His work has implications for various serologic reactions, enhancing the quality and reliability of testing methods.
Latest Patents
Matsuzawa holds a patent for a serological reagent and its preparation. The patent describes a latex reagent that is created by allowing latex particles to adsorb a nonionic surfactant of the ethylene oxide type. This process sensitizes the latex particles with a serologically active substance, such as an antigen or antibody, and suspends them in an aqueous solvent. The resulting latex reagent exhibits excellent quality, characterized by high stability and sensitivity in serologic reactions. This innovation can be employed advantageously in a wide range of serologic applications.
Career Highlights
Shigetaka Matsuzawa is associated with Takeda Chemical Industries, Inc., a leading company in the pharmaceutical and biotechnology sectors. His work at Takeda has allowed him to focus on developing advanced serological reagents that contribute to medical diagnostics and research.
Collaborations
Matsuzawa has collaborated with notable colleagues, including Yukio Sato and Seijun Wada. These collaborations have likely enriched his research and development efforts, fostering innovation in the field of serology.
Conclusion
Shigetaka Matsuzawa's contributions to the development of serological reagents highlight his role as an important inventor in the medical field. His innovative patent demonstrates the potential for improved diagnostic methods, benefiting both researchers and healthcare professionals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
